7 Matching Annotations
  1. Feb 2025
  2. www.nature.com www.nature.com
    Molecular mechanisms of CAND2 in regulating SCF ubiquitin ligases
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41467-025-57065-5
  3. Mar 2024
  4. www.sciencedirect.com www.sciencedirect.com
    Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945624000874
  5. Sep 2023
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10481131/
  7. Jul 2023
  8. 52.53.155.43 52.53.155.43
    cd-23-0475-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/ab02200bf4457c1e8196af2525f73574a3d0dd99/cd-23-0475-html.html
  9. Sep 2020
  10. elifesciences.org elifesciences.org
    Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    elifesciences.org/articles/44161
  11. Jan 2020
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Untitled document
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC6436895/
  13. Nov 2018
  14. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC5720590/